propionyl-l-carnitine acne Propionylcarnitine | C10H19NO4 | CID 188824 Direct calcitonin gene-related peptide inhibition

doi: 10.1189/jlb.0404216 33 CrossARJonesOT

Glossary GPX4 glutathione peroxidase 4 TF transferrin TFR1 transferrin receptor 1 STEAP3 six-transmembrane epithelial antigen of the prostate 3 ALOX arachidonate lipoxygenases HMOX1 heme oxygenase 1 HNE 4-hydroxynonenal MDA malondialdehyde LOOHs lipid hydroperoxide AA arachidonic acid AdA adrenic acid ACSL4 long-chain acyl-CoA synthetase 4 PE phosphatidylethanolamine H 2 O 2 hydrogen peroxide Fe 2+ ferrous iron Fe 3+ ferric iron NOX NADPH oxidase PUFAs polyunsaturated fatty acids PLOOH phospholipid hydroperoxides LOX lipoxygenase GSH glutathione System x c cysteine/glutamate antiporter xCT/SLC7A11 solute carrier family 7 member 11 FSP1 ferroptosis suppressor protein 1 CoQ1 coenzyme Q10 NAD(P)H nicotinamide adenine dinucleotide phosphate CoQH2 Coenzyme Q10 BH4 dihydrofolate to tetrahydrofolate Nrf2 nuclear factor erythroid 2-related factor 2 Keap1 Kelch-like ECH-associated protein 1 ARE antioxidant response elements GCL glutamate cysteine ligase GSS glutathione synthetase HO-1 heme oxygenase-1 USP7 ubiquitin-specific protease 7 SAT1 spermidine/spermine N1-acetyltransferase 1 IPP isopentenyl pyrophosphate MVA pathway mevalonate pathway GCLC glutamate-cysteine ligase catalytic subunit -KG -ketoglutarate VDAC2/3 voltage-dependent anion channels2/3 ETC electron transfer chain ROS reactive oxygen species STAT3 transcription 3 Fer-1 ferroptosis inhibitor ferrostatin-1 GRh3 Ginsenoside Rh3 GRh4 Ginsenoside Rh4 GRg5 Ginsenoside Rg5 GRK1 Ginsenoside RK1 GCK Ginsenoside CK NCOA4 nuclear receptor coactivator 4 NR3C1 nuclear receptor subfamily 3 group C member 1 FOXO1 forkhead box protein O1 PLOO phospholipid peroxyl radicals AMPK activated protein kinase PGC1 peroxisome proliferators-activated receptor TRIB3 tribbles protein kinase 3 p-DRP1 phospho dynamin-related protein 1 GSK3 glycogen synthase kinase-3 beta NQO1 non-Q-dependent Reductase PDK1 pyruvate dehydrogenase kinase 1 LDH lactate dehydrogenase TCA cycle tricarboxylic acid cycle TCF4 T cell factor 4 ALOXE3 arachidonate lipoxygenase 3 HIC1 hypermethylated in cancer 1 LAMP-1 lysosomal associated membrane protein 1 SOD4 superoxide dismutase 4 GDF15 growth differentiation factor 15 LIP labile iron pool DRP1 dynamin-related protein 1 Camk2 calcium/calmodulin-dependent protein kinase II NQO1 non-Q-dependent Reductase TCA cycle tricarboxylic acid cycle;GPX4, glutathione peroxidase 4 OH hydroxyl radicals O 2 superoxide radicals GSSH oxidized glutathione DMT1 divalent metal transporter 1 LPO lipid peroxidation STAT1 transcription 1 COX-2 Cyclooxygenase-2 FTH1 ferritin heavy chain 1 API APG, apigenin Cyt c Cytochrome C Bax BCL2-Associated X Protein Bcl-2 B-cell lymphoma-2 HSP70 heat shock protein 70 NIR NearInfrared INF- interferon- PD-L1 programmed cell death ligand 1 DC dendritic cells DOX doxorubicin EGCG epigallocatechin-3-gallate NPs nanoparticles PL piperlongumine LDH lactate dehydrogenase SQS squalene synthase ACC acetyl-CoA carboxylase

Research involving peptide fragments such as AOD-9604 often focuses on peptide structure-activity relationships, molecular signalling mechanisms, and peptide interaction dynamics in controlled laboratory environments

Limited Side Effects and Well Accepted AOD 9604 therapy has a marked advantage in its safety profile